Cargando…

Can we protect the brain via preconditioning? Role of microRNAs in neuroprotection

Detalles Bibliográficos
Autores principales:	Quinlan, Sean, Jimenez-Mateos, Eva M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828988/ https://www.ncbi.nlm.nih.gov/pubmed/27127462 http://dx.doi.org/10.4103/1673-5374.179037

Ejemplares similares

Role of MicroRNAs in innate neuroprotection mechanisms due to preconditioning of the brain
por: Jimenez-Mateos, Eva M.
Publicado: (2015)

Neuroprotection induced by NMDA preconditioning as a strategy to understand brain tolerance mechanism
por: Constantino, Leandra C., et al.
Publicado: (2015)

MicroRNAs in muscle wasting
por: Suzuki, Tsuyoshi, et al.
Publicado: (2019)

Can we treat neurodegenerative diseases by preventing an age-related decline in microRNA expression?
por: Vinnikov, Ilya A., et al.
Publicado: (2017)

MicroRNAs and Their Targetomes in Tumor-Immune Communication
por: Cho, Sunglim, et al.
Publicado: (2020)

MicroRNA-323-5p Involved in Dexmedetomidine Preconditioning Impart Neuroprotection
por: Seong, Hyunyoung, et al.
Publicado: (2023)

LINking microRNAs, kidney development, and Wilms tumors
por: Hohenstein, Peter, et al.
Publicado: (2014)

Specific microRNAs are involved in the reno-protective effects of sevoflurane preconditioning and ischemic preconditioning against ischemia reperfusion injury in rats
por: Yamamoto, Makiko, et al.
Publicado: (2020)

Haploinsufficiency of Tumor Suppressor Genes is Driven by the Cumulative Effect of microRNAs, microRNA Binding Site Polymorphisms and microRNA Polymorphisms: An In silico Approach
por: Manikandan, Mayakannan, et al.
Publicado: (2012)

Clinical implications of microRNAs in liver cancer stem cells
por: Chai, Stella, et al.
Publicado: (2013)

Pediatric Diabetic Nephropathy: Novel Insights from microRNAs
por: Lanzaro, Francesca, et al.
Publicado: (2023)

Sex disparity in cancer: roles of microRNAs and related functional players
por: Carè, Alessandra, et al.
Publicado: (2018)

Synaptosome microRNAs: emerging synapse players in aging and Alzheimer’s disease
por: Kumar, Subodh
Publicado: (2022)

Identical MicroRNAs Regulate Liver Protection during Anaesthetic and Ischemic Preconditioning in Rats: An animal study
por: Morita, Tomonori, et al.
Publicado: (2015)

β-Cell MicroRNAs: Small but Powerful
por: Filios, Stephen R., et al.
Publicado: (2015)

Can we switch production of toxic Aβ oligomers to neuroprotective Aβ monomers to allow synapse regeneration?
por: Bate, Clive
Publicado: (2017)

The neuroprotective effects of (S)-3,5-dihydroxyphenylglycine preconditioning in middle cerebral artery occluded rats: a perspective as a contrivance for stroke
por: Nik Ramli, Nik Nasihah, et al.
Publicado: (2015)

Targeting the body to protect the brain: inducing neuroprotection with remotely-applied near infrared light
por: Johnstone, Daniel M., et al.
Publicado: (2015)

Mitochondria Localized microRNAs: An Unexplored miRNA Niche in Alzheimer’s Disease and Aging
por: Rivera, Jazmin, et al.
Publicado: (2023)

Can glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality?
por: Basalay, Maryna V., et al.
Publicado: (2020)

Back to the beginning: can we stop brain injury before it starts?
por: Davidson, Joanne O., et al.
Publicado: (2022)

Fine-tuning the response of growth cones to guidance cues: a perspective on the role of microRNAs
por: Walker, Sarah E., et al.
Publicado: (2019)

View on microRNAs as a potential tool to fight blindness: focus on Müller glia and gliosis
por: Wohl, Stefanie Gabriele
Publicado: (2021)

Emerging small-molecule therapeutic approaches for Alzheimer's disease and Parkinson's disease based on targeting microRNAs
por: Abdelrahman, Somaya A., et al.
Publicado: (2021)

On the preconditions for large-scale collective action
por: Jagers, Sverker C., et al.
Publicado: (2019)

Controlling SIRT1 expression by microRNAs in health and metabolic disease
por: Lee, Jiyoung, et al.
Publicado: (2010)

The Role of MicroRNAs in Myocarditis—What Can We Learn from Clinical Trials?
por: Grodzka, Olga, et al.
Publicado: (2022)

Polarizing the immune system towards neuroprotection in brain ischemia
por: Amantea, Diana
Publicado: (2016)

Can we prevent childhood Leukaemia?
por: Greaves, Mel, et al.
Publicado: (2021)

Neuroprotective effects and mechanisms of fentanyl preconditioning against brain ischemia
por: Wang, X
Publicado: (2006)

MicroRNAs in β-Cell Biology, Insulin Resistance, Diabetes and Its Complications
por: Fernandez-Valverde, Selene L., et al.
Publicado: (2011)

Can We Quantify If It’s a CURE?
por: Beck, Christopher W., et al.
Publicado: (2023)

MicroRNAs and metabolic disorders – where are we heading?
por: Sliwinska, Agnieszka, et al.
Publicado: (2017)

Export of microRNAs and microRNA-protective protein by mammalian cells
por: Wang, Kai, et al.
Publicado: (2010)

Adipose-brain crosstalk: do adipokines have a role in neuroprotection?
por: Little, Jonathan P., et al.
Publicado: (2015)

microRNAs and oligometastasis
por: Khodarev, Nikolai N., et al.
Publicado: (2015)

Anesthetic Preconditioning as Endogenous Neuroprotection in Glaucoma
por: Chou, Tsung-Han, et al.
Publicado: (2018)

Can microRNAs act as biomarkers of aging?
por: Kashyap, Luv
Publicado: (2011)

Can microRNAs keep inflammasomes in check?
por: Qazi, Omar, et al.
Publicado: (2013)

Hypoxic preconditioning — A nonpharmacological approach in COVID-19 prevention
por: Hertzog, Radu Gabriel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eppqcccna92sr8b3r6r9s7r4jv